Homozygous deletion of the activin A receptor, type IB gene is associated with an aggressive cancer phenotype in pancreatic cancer

Yosuke Togashi, Hiroki Sakamoto, Hidetoshi Hayashi, Masato Terashima, Marco A. de Velasco, Yoshihiko Fujita, Yasuo Kodera, Kazuko Sakai, Shuta Tomida, Masayuki Kitano, Akihiko Ito, Masatoshi Kudo, Kazuto Nishio

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Background: Transforming growth factor, beta (TGFB) signal is considered to be a tumor suppressive pathway based on the frequent genomic deletion of the SMAD4 gene in pancreatic cancer (PC); however; the role of the activin signal, which also belongs to the TGFB superfamily, remains largely unclear. Methods and results: We found a homozygous deletion of the activin A receptor, type IB (ACVR1B) gene in 2 out of 8 PC cell lines using array-comparative genomic hybridization, and the absence of ACVR1B mRNA and protein expression was confirmed in these 2 cell lines. Activin A stimulation inhibited cellular growth and increased the phosphorylation level of SMAD2 and the expression level of p21CIP1/WAF1 in the Sui66 cell line (wild-type ACVR1B and SMAD4 genes) but not in the Sui68 cell line (homozygous deletion of ACVR1B gene). Stable ACVR1B-knockdown using short hairpin RNA cancelled the effects of activin A on the cellular growth of the PC cell lines. In addition, ACVR1B-knockdown significantly enhanced the cellular growth and colony formation abilities, compared with controls. In a xenograft study, ACVR1B-knockdown resulted in a significantly elevated level of tumorigenesis and a larger tumor volume, compared with the control. Furthermore, in clinical samples, 6 of the 29 PC samples (20.7%) carried a deletion of the ACVR1B gene, while 10 of the 29 samples (34.5%) carried a deletion of the SMAD4 gene. Of note, 5 of the 6 samples with a deletion of the ACVR1B gene also had a deletion of the SMAD4 gene. Conclusion: We identified a homozygous deletion of the ACVR1B gene in PC cell lines and clinical samples and proposed that the deletion of the ACVR1B gene may mediate an aggressive cancer phenotype in PC. Our findings provide novel insight into the role of the activin signal in PC.

Original languageEnglish
Article number126
JournalMolecular Cancer
Volume13
Issue number1
DOIs
Publication statusPublished - May 27 2014
Externally publishedYes

Fingerprint

Activin Receptors
Gene Deletion
Pancreatic Neoplasms
Phenotype
Cell Line
Genes
Neoplasms
Activins
Transforming Growth Factor beta
Growth
Comparative Genomic Hybridization
activin A
Tumor Burden
Heterografts
Small Interfering RNA
Carcinogenesis
Phosphorylation
Messenger RNA

Keywords

  • Activin A receptor
  • Activin signal
  • Pancreatic cancer
  • SMAD4
  • Type IB

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Medicine
  • Oncology
  • Medicine(all)

Cite this

Togashi, Y., Sakamoto, H., Hayashi, H., Terashima, M., de Velasco, M. A., Fujita, Y., ... Nishio, K. (2014). Homozygous deletion of the activin A receptor, type IB gene is associated with an aggressive cancer phenotype in pancreatic cancer. Molecular Cancer, 13(1), [126]. https://doi.org/10.1186/1476-4598-13-126

Homozygous deletion of the activin A receptor, type IB gene is associated with an aggressive cancer phenotype in pancreatic cancer. / Togashi, Yosuke; Sakamoto, Hiroki; Hayashi, Hidetoshi; Terashima, Masato; de Velasco, Marco A.; Fujita, Yoshihiko; Kodera, Yasuo; Sakai, Kazuko; Tomida, Shuta; Kitano, Masayuki; Ito, Akihiko; Kudo, Masatoshi; Nishio, Kazuto.

In: Molecular Cancer, Vol. 13, No. 1, 126, 27.05.2014.

Research output: Contribution to journalArticle

Togashi, Y, Sakamoto, H, Hayashi, H, Terashima, M, de Velasco, MA, Fujita, Y, Kodera, Y, Sakai, K, Tomida, S, Kitano, M, Ito, A, Kudo, M & Nishio, K 2014, 'Homozygous deletion of the activin A receptor, type IB gene is associated with an aggressive cancer phenotype in pancreatic cancer', Molecular Cancer, vol. 13, no. 1, 126. https://doi.org/10.1186/1476-4598-13-126
Togashi, Yosuke ; Sakamoto, Hiroki ; Hayashi, Hidetoshi ; Terashima, Masato ; de Velasco, Marco A. ; Fujita, Yoshihiko ; Kodera, Yasuo ; Sakai, Kazuko ; Tomida, Shuta ; Kitano, Masayuki ; Ito, Akihiko ; Kudo, Masatoshi ; Nishio, Kazuto. / Homozygous deletion of the activin A receptor, type IB gene is associated with an aggressive cancer phenotype in pancreatic cancer. In: Molecular Cancer. 2014 ; Vol. 13, No. 1.
@article{500e36f93dc84f0d86ab0f57efc15500,
title = "Homozygous deletion of the activin A receptor, type IB gene is associated with an aggressive cancer phenotype in pancreatic cancer",
abstract = "Background: Transforming growth factor, beta (TGFB) signal is considered to be a tumor suppressive pathway based on the frequent genomic deletion of the SMAD4 gene in pancreatic cancer (PC); however; the role of the activin signal, which also belongs to the TGFB superfamily, remains largely unclear. Methods and results: We found a homozygous deletion of the activin A receptor, type IB (ACVR1B) gene in 2 out of 8 PC cell lines using array-comparative genomic hybridization, and the absence of ACVR1B mRNA and protein expression was confirmed in these 2 cell lines. Activin A stimulation inhibited cellular growth and increased the phosphorylation level of SMAD2 and the expression level of p21CIP1/WAF1 in the Sui66 cell line (wild-type ACVR1B and SMAD4 genes) but not in the Sui68 cell line (homozygous deletion of ACVR1B gene). Stable ACVR1B-knockdown using short hairpin RNA cancelled the effects of activin A on the cellular growth of the PC cell lines. In addition, ACVR1B-knockdown significantly enhanced the cellular growth and colony formation abilities, compared with controls. In a xenograft study, ACVR1B-knockdown resulted in a significantly elevated level of tumorigenesis and a larger tumor volume, compared with the control. Furthermore, in clinical samples, 6 of the 29 PC samples (20.7{\%}) carried a deletion of the ACVR1B gene, while 10 of the 29 samples (34.5{\%}) carried a deletion of the SMAD4 gene. Of note, 5 of the 6 samples with a deletion of the ACVR1B gene also had a deletion of the SMAD4 gene. Conclusion: We identified a homozygous deletion of the ACVR1B gene in PC cell lines and clinical samples and proposed that the deletion of the ACVR1B gene may mediate an aggressive cancer phenotype in PC. Our findings provide novel insight into the role of the activin signal in PC.",
keywords = "Activin A receptor, Activin signal, Pancreatic cancer, SMAD4, Type IB",
author = "Yosuke Togashi and Hiroki Sakamoto and Hidetoshi Hayashi and Masato Terashima and {de Velasco}, {Marco A.} and Yoshihiko Fujita and Yasuo Kodera and Kazuko Sakai and Shuta Tomida and Masayuki Kitano and Akihiko Ito and Masatoshi Kudo and Kazuto Nishio",
year = "2014",
month = "5",
day = "27",
doi = "10.1186/1476-4598-13-126",
language = "English",
volume = "13",
journal = "Molecular Cancer",
issn = "1476-4598",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Homozygous deletion of the activin A receptor, type IB gene is associated with an aggressive cancer phenotype in pancreatic cancer

AU - Togashi, Yosuke

AU - Sakamoto, Hiroki

AU - Hayashi, Hidetoshi

AU - Terashima, Masato

AU - de Velasco, Marco A.

AU - Fujita, Yoshihiko

AU - Kodera, Yasuo

AU - Sakai, Kazuko

AU - Tomida, Shuta

AU - Kitano, Masayuki

AU - Ito, Akihiko

AU - Kudo, Masatoshi

AU - Nishio, Kazuto

PY - 2014/5/27

Y1 - 2014/5/27

N2 - Background: Transforming growth factor, beta (TGFB) signal is considered to be a tumor suppressive pathway based on the frequent genomic deletion of the SMAD4 gene in pancreatic cancer (PC); however; the role of the activin signal, which also belongs to the TGFB superfamily, remains largely unclear. Methods and results: We found a homozygous deletion of the activin A receptor, type IB (ACVR1B) gene in 2 out of 8 PC cell lines using array-comparative genomic hybridization, and the absence of ACVR1B mRNA and protein expression was confirmed in these 2 cell lines. Activin A stimulation inhibited cellular growth and increased the phosphorylation level of SMAD2 and the expression level of p21CIP1/WAF1 in the Sui66 cell line (wild-type ACVR1B and SMAD4 genes) but not in the Sui68 cell line (homozygous deletion of ACVR1B gene). Stable ACVR1B-knockdown using short hairpin RNA cancelled the effects of activin A on the cellular growth of the PC cell lines. In addition, ACVR1B-knockdown significantly enhanced the cellular growth and colony formation abilities, compared with controls. In a xenograft study, ACVR1B-knockdown resulted in a significantly elevated level of tumorigenesis and a larger tumor volume, compared with the control. Furthermore, in clinical samples, 6 of the 29 PC samples (20.7%) carried a deletion of the ACVR1B gene, while 10 of the 29 samples (34.5%) carried a deletion of the SMAD4 gene. Of note, 5 of the 6 samples with a deletion of the ACVR1B gene also had a deletion of the SMAD4 gene. Conclusion: We identified a homozygous deletion of the ACVR1B gene in PC cell lines and clinical samples and proposed that the deletion of the ACVR1B gene may mediate an aggressive cancer phenotype in PC. Our findings provide novel insight into the role of the activin signal in PC.

AB - Background: Transforming growth factor, beta (TGFB) signal is considered to be a tumor suppressive pathway based on the frequent genomic deletion of the SMAD4 gene in pancreatic cancer (PC); however; the role of the activin signal, which also belongs to the TGFB superfamily, remains largely unclear. Methods and results: We found a homozygous deletion of the activin A receptor, type IB (ACVR1B) gene in 2 out of 8 PC cell lines using array-comparative genomic hybridization, and the absence of ACVR1B mRNA and protein expression was confirmed in these 2 cell lines. Activin A stimulation inhibited cellular growth and increased the phosphorylation level of SMAD2 and the expression level of p21CIP1/WAF1 in the Sui66 cell line (wild-type ACVR1B and SMAD4 genes) but not in the Sui68 cell line (homozygous deletion of ACVR1B gene). Stable ACVR1B-knockdown using short hairpin RNA cancelled the effects of activin A on the cellular growth of the PC cell lines. In addition, ACVR1B-knockdown significantly enhanced the cellular growth and colony formation abilities, compared with controls. In a xenograft study, ACVR1B-knockdown resulted in a significantly elevated level of tumorigenesis and a larger tumor volume, compared with the control. Furthermore, in clinical samples, 6 of the 29 PC samples (20.7%) carried a deletion of the ACVR1B gene, while 10 of the 29 samples (34.5%) carried a deletion of the SMAD4 gene. Of note, 5 of the 6 samples with a deletion of the ACVR1B gene also had a deletion of the SMAD4 gene. Conclusion: We identified a homozygous deletion of the ACVR1B gene in PC cell lines and clinical samples and proposed that the deletion of the ACVR1B gene may mediate an aggressive cancer phenotype in PC. Our findings provide novel insight into the role of the activin signal in PC.

KW - Activin A receptor

KW - Activin signal

KW - Pancreatic cancer

KW - SMAD4

KW - Type IB

UR - http://www.scopus.com/inward/record.url?scp=84902119638&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902119638&partnerID=8YFLogxK

U2 - 10.1186/1476-4598-13-126

DO - 10.1186/1476-4598-13-126

M3 - Article

C2 - 24886203

AN - SCOPUS:84902119638

VL - 13

JO - Molecular Cancer

JF - Molecular Cancer

SN - 1476-4598

IS - 1

M1 - 126

ER -